Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B
- PMID: 11451198
- DOI: 10.1023/a:1010639313832
Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B
Abstract
Cell invasion is a nature of malignant gliomas, demeriting to many efforts of the treatment. Matrix metalloproteinase (MMP) is acknowledged as a key factor in this complicated process. The aim of this study was to investigate whether inhibition of MMP activity in malignant glioma cells could be achieved by a novel agent, BE16627B (BE). Malignant glioma cell lines, U87MG, U251MG, and U373MG, were employed to evaluate inhibitory effect on zymogram, type IV collagenolysis assay, and haptoinvasion assay for 24 h exposure of BE, following preliminar
Similar articles
-
Apoptotic induction by BE16627B on human malignant glioma cell lines by an anti-matrix metalloproteinase agent.Brain Tumor Pathol. 2003;20(1):13-9. doi: 10.1007/BF02478942. Brain Tumor Pathol. 2003. PMID: 14604227
-
Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study.J Neurooncol. 2000 Jul;48(3):217-23. doi: 10.1023/a:1006424424119. J Neurooncol. 2000. PMID: 11100819
-
Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.J Neurosurg. 2014 Dec;121(6):1483-91. doi: 10.3171/2014.8.JNS131991. Epub 2014 Oct 10. J Neurosurg. 2014. PMID: 25303017
-
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.J Neurooncol. 2001 Jun;53(2):177-85. doi: 10.1023/a:1012209518843. J Neurooncol. 2001. PMID: 11716069 Review.
-
[CDK and MMP inhibitors].Gan To Kagaku Ryoho. 1997 Sep;24(11):1547-62. Gan To Kagaku Ryoho. 1997. PMID: 9309154 Review. Japanese.
Cited by
-
Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells.Am J Pathol. 2003 May;162(5):1403-9. doi: 10.1016/S0002-9440(10)64273-3. Am J Pathol. 2003. PMID: 12707023 Free PMC article.
-
Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide.J Neurooncol. 2002 May;58(1):1-11. doi: 10.1023/a:1015894513482. J Neurooncol. 2002. PMID: 12160135
-
BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.J Neurooncol. 2008 Jul;88(3):261-72. doi: 10.1007/s11060-008-9575-8. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398576 Free PMC article.
-
Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.J Neurooncol. 2005 Mar;72(1):1-9. doi: 10.1007/s11060-004-1392-0. J Neurooncol. 2005. PMID: 15803368
-
Drug-induced apoptosis by a matrix metalloproteinase inhibitor, SI-27 on human malignant glioma cell lines; in vitro study.J Neurooncol. 2004 Jan;66(1-2):91-9. doi: 10.1023/b:neon.0000013491.78909.43. J Neurooncol. 2004. PMID: 15015774
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources